Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.88%
+5.81%
-7.54%
+2.96%
+26.52%
ABT
Abbott Laboratories
$131.53
Login to see Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Upgraded on attractively valued
Trading below its fair value
Investors confidence is positive
Risk Analysis
Earnings are forecast to decrease
Chart
$132.74 (-0.91%)
$124.42 (+5.71%)
$133.05 (-1.14%)
$114.22 (+15.15%)
ABT has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
ABT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to decrease
Trading below its fair value
ABT Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ABT Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayABT Earnings
The TTM reflects 12-month period, providing review of ABT financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
CVKD
13.99
+2.72%
PFE
24.73
-0.20%
NVS
129.12
-0.70%
MTNB
1.84
+7.31%
GRFS
9.45
+1.39%
What is ABT current stock price?
What are ABT stock strengths?
What risks are associated with ABT stock?
When is ABT next earnings report?
What is ABT market cap and volume?
What is ABT's current Stock IQ?
Should I buy ABT stock right now?
Is ABT a Strong Buy right now?
What does a 'Strong Buy' rating mean for ABT?
What does a 'Strong Sell' rating mean for ABT?
What factors influence ABT's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.88%
+5.81%
-7.54%
+2.96%
+26.52%
ABT
Abbott Laboratories
Current Price
$131.53
Stock Insights
Strengths
Upgraded on attractively valued
Trading below its fair value
Investors confidence is positive
Risk Analysis
Earnings are forecast to decrease
Linked to ABT
CVKD
13.99
+2.72%
PFE
24.73
-0.20%
NVS
129.12
-0.70%
MTNB
1.84
+7.31%
GRFS
9.45
+1.39%
Login to unlock Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$132.74 (-0.91%)
$124.42 (+5.71%)
$133.05 (-1.14%)
$114.22 (+15.15%)
ABT Analysts Opinion
ABT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to decrease
Trading below its fair value
ABT Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ABT Street view is bullish and have positive views on the near-term outlook
ABT has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayABT Earnings
The TTM data reflects the most recent 12-month period, providing overview of ABT financial performance.
ABT Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
ABT Latest Analysis
Ex-Dividend Reminder: Abbott Laboratories AbbVie and ARMOUR Residential REIT . Looking at the universe of stocks we cover at Dividend Channel on 10/15/25 Abbott Laboratories (Symbol: ABT) AbbVie Inc (Symbol: ABBV) and ARMOUR Residential REIT Inc. (Symbol: ARR) will all trade ex-dividend for their respective upcoming dividends. Abbott Laboratories will
Today
Abbott to Report Q3 Earnings: Medical Devices Arm in Focus. ABTs Q3 results may show strength in Medical Devices and Nutrition offsetting softness in Diagnostics.
Fri Oct 10, 2025
Wall Streets Insights Into Key Metrics Ahead of Abbott (ABT) Q3 Earnings. Evaluate the expected performance of Abbott (ABT) for the quarter ended September 2025 looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Fri Oct 10, 2025
Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat
Fri Oct 10, 2025
ABT Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat
Wed Oct 8, 2025
Evercore ISI Group Maintains Abbott Laboratories (ABT) Outperform Recommendation. Fintel reports that on October 7 2025 Evercore ISI Group maintained coverage of Abbott Laboratories (NYSE:ABT) with a Outperform recommendation. Analyst Price Forecast Suggests 8.70% Upside
Wed Oct 8, 2025
Abbott Laboratories (ABT): A Healthcare Leader Powering the List of Profitable Dividend Stocks. Abbott Laboratories (NYSE:ABT) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Abbott Laboratories (NYSE:ABT) has long been a household name in the healthcare world offering products that reach millions of people every day. Its operations span several major areas including prescription medicines medical devices diagnostics and nutrition. The compa
Wed Oct 8, 2025
Forecasting The Future: 12 Analyst Projections For Abbott Laboratories. Abbott Laboratories (NYSE:ABT) has been analyzed by 12 analysts in the last three months revealing a diverse range of perspectives from ish to bearish.In the table below you'.ll find a summary of their recent ratings revealing the shifting sentiments over the past 30 days and comparing them to the previous months.4530001000000000000044300Analysts have set 12-month price targets for Abbott Laboratories revealing an averag
Tue Oct 7, 2025
Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat
Mon Oct 6, 2025
Abbott (ABT) Laps the Stock Market: Heres Why. Abbott (ABT) reached $134.59 at the closing of the latest trading day reflecting a 1.2% change compared to its last close.
Fri Oct 3, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings
Leaders